XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
Revenues $ 722 $ 376 $ 2,241 $ 2,114
Cost of revenues 533 243 1,718 889
Gross profit 189 133 523 1,225
Operating expenses:        
Research and development 221 249 1,723 557
Selling and marketing 812 181 1,878 545
General and administrative 1,403 673 4,997 2,335
Total operating expenses 2,436 1,103 8,598 3,437
Loss from operations (2,247) (970) (8,075) (2,212)
Interest expense (53) (33) (250) (101)
Financial income, net 2,845 8 3,104 53
Income (loss) before taxes on income 545 (995) (5,221) (2,260)
Income tax expenses (35) (3) (112) (14)
Net income (loss) 510 (998) (5,333) (2,274)
Preferred Stock dividends        
8% dividend on Convertible Preferred Series X (758) (1,102)
9% dividend on Convertible Preferred Series H (223) (223)
Deemed dividend for down round on Series H (399) (399)
Deemed contribution on repurchase of Preferred Series X 90 90
Deemed contribution 3,815
Net loss available to common stockholders $ (780) $ (998) $ (3,152) $ (2,274)
Basic net loss available for holders of common stock [1] $ (0.91) $ (3.56) $ (6.69) $ (8.38)
Diluted net loss available for holders of common stock [1] $ (0.91) $ (3.56) $ (6.69) $ (8.38)
Weighted average common stock outstanding, basic [1] 858,434 280,318 470,940 271,284
Weighted average common stock outstanding, diluted [1] 858,434 280,318 470,940 271,284
Comprehensive loss:        
Net income (loss) $ 510 $ (998) $ (5,333) $ (2,274)
Change in foreign currency translation adjustments (2) (3) (7) (8)
Comprehensive income (loss) available to common stockholders $ 508 $ (1,001) $ (5,340) $ (2,282)
[1] Adjusted to reflect the reverse stock splits (see note 6).